Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 81 (3), 574-579
- https://doi.org/10.1016/0091-6749(88)90197-2
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- TERFENADINE (SELDANE) IS A POTENT AND SELECTIVE HISTAMINE-H1 RECEPTOR ANTAGONIST IN ASTHMATIC AIRWAYSPublished by Elsevier ,1987
- Increased compound 48/80 induced local histamine release from nonlesional skin of patients with chronic urticariaJournal of Allergy and Clinical Immunology, 1986
- Studies of the cellular infiltrate of chronic idiopathic urticaria: Prominence of T-lymphocytes, monocytes, and mast cellsJournal of Allergy and Clinical Immunology, 1986
- Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double‐blind study.British Journal of Clinical Pharmacology, 1985
- MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TERFENADINE IN SEASONAL ALLERGIC RHINITIS AND CONJUNCTIVITIS1985
- Treatment of chronic idiopathic urticaria with terfenadineClinical and Experimental Allergy, 1984
- Histologic studies of chronic idiopathic urticariaJournal of Allergy and Clinical Immunology, 1983
- Assessment of tissue fluid histamine levels in patients with urticariaJournal of Allergy and Clinical Immunology, 1978